Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12508020 | 0.87 | BTK (0.43) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL764528 | 0.87 | BTK (0.43) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL12507941 | 0.87 | BTK (0.43) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL31084798 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL31084796 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL31084799 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL31084797 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL15078163 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL31084801 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 | |
| SCHEMBL31084800 | 0.86 | BTK (0.46) | BTKKDM1AMAOBMAOANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2980067-B1 | PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9447118-B2 | Preparation method of optically active diamine compound | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-09-20 | — | — | US | disclosed |
| US-9447118-B2 | Preparation method of optically active diamine compound | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-09-20 | — | — | US | disclosed |
| EP-2980067-A1 | PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-20160016974-A1 | PREPARATION METHOD OF OPTICALLY ACTIVE DIAMINE COMPOUND | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20160016974-A1 | PREPARATION METHOD OF OPTICALLY ACTIVE DIAMINE COMPOUND | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20150353577-A1 | METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| US-20150353577-A1 | METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| US-9175012-B2 | Method for producing optically active diamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-11-03 | — | — | US | disclosed |
| US-9175012-B2 | Method for producing optically active diamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-11-03 | — | — | US | disclosed |
| US-8901345-B2 | Process for preparation of optically active diamine derivative salt | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20130165657-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-06-27 | — | — | US | disclosed |
| US-20130165657-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-06-27 | — | — | US | disclosed |
| US-8357808-B2 | Process for producing diamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-22 | — | — | US | disclosed |
| US-8357808-B2 | Process for producing diamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-22 | — | — | US | disclosed |
| US-20120041206-A1 | PROCESS FOR PRODUCING DIAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120041206-A1 | PROCESS FOR PRODUCING DIAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120035369-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE DIAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035369-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE DIAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2407450-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE DIAMINE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2012-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353577-A1 | METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONE | F7, MAOA, F13A1 | BTK 635/4885KDM1A 399/4885MAOB 39/4885 |
| US-20120041206-A1 | PROCESS FOR PRODUCING DIAMINE DERIVATIVE | TFPI, TFPI2, DAO | BTK 257/4885KDM1A 507/4885MAOB 46/4885 |
| US-20130165657-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE DIAMINE DERIVATIVE SALT | TFPI, F12, TFPI2 | BTK 235/4885KDM1A 317/4885MAOB 142/4885 |
| US-20160016974-A1 | PREPARATION METHOD OF OPTICALLY ACTIVE DIAMINE COMPOUND | F12, F8, F11 | BTK 2151/4885KDM1A 1199/4885MAOB 96/4885 |
| US-20120035369-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE DIAMINE DERIVATIVE | F12, DAO, TFPI | BTK 893/4885KDM1A 158/4885MAOB 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.